Cardiovascular Evidence-Based Medicine
How would you like to harm your patient? Azithromycin and Increased CV Death
It wasn’t too long ago that I reviewed pulmonary infections for a morning report (see summary here). We reviewed some fun facts including: – 10 % of HCAP have atypical infections indicating the use of Azithromycin. – For outpatient CAP treatment, IDSA recommends Azithromycin (other option being doxy) – For Read more…